[Clinical trial of Albicort Compositum tincture in dermatology].
D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D001548:Benzalkonium Compounds / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use; D000431:Ethanol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012459:Salicylates / Q000627:therapeutic use*; D012871:Skin Diseases / Q000188:drug therapy*; D014222:Triamcinolone Acetonide / Q000627:therapeutic use*
D000891:Anti-Infective Agents, Local; D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D001548:Benzalkonium Compounds; D003879:Dermatologic Agents; D012459:Salicylates; D000431:Ethanol; D014222:Triamcinolone Acetonide
Essai clinique d'Albert Compositum teinture en dermatologie.